KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Change in Inventory (2016 - 2024)

Nektar Therapeutics (NKTR) has 15 years of Change in Inventory data on record, last reported at -$1.3 million in Q4 2024.

  • For Q4 2024, Change in Inventory fell 21.85% year-over-year to -$1.3 million; the TTM value through Sep 2025 reached -$1.3 million, down 396.2%, while the annual FY2024 figure was -$497000.0, 28.9% up from the prior year.
  • Change in Inventory reached -$1.3 million in Q4 2024 per NKTR's latest filing, down from -$123000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.4 million in Q4 2020 and bottomed at -$2.4 million in Q3 2023.
  • Average Change in Inventory over 5 years is $267050.0, with a median of $389500.0 recorded in 2020.
  • The widest YoY moves for Change in Inventory: up 570.38% in 2023, down 838.62% in 2023.
  • A 5-year view of Change in Inventory shows it stood at $2.4 million in 2020, then tumbled by 80.38% to $471000.0 in 2021, then crashed by 69.21% to $145000.0 in 2022, then crashed by 838.62% to -$1.1 million in 2023, then fell by 21.85% to -$1.3 million in 2024.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$1.3 million in Q4 2024, -$123000.0 in Q3 2024, and -$212000.0 in Q2 2024.